VISUAL OUTCOMES AND ADHERENCE CHALLENGES IN PROLIFERATIVE DIABETIC RETINOPATHY ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY IN THE CLINICAL PRACTICE SETTING
The frequent follow-up appointments and repeat treatments necessary for anti-VEGF monotherapy in PDR can pose challenges to maintaining the required schedule and can result in worse visual acuity outcomes and increased ocular complications.
Authors
- Rusirini Fernando (ORCID: https://orcid.org/0009-0001-3627-0833)
- Nick Boucher (ORCID: https://orcid.org/0000-0002-3657-575X)
- Adrienne W. Scott (ORCID: https://orcid.org/0000-0003-2607-1184)
- Jay Maturi (ORCID: https://orcid.org/0000-0002-9995-2962)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Veolia (United States) (US)
Publication Details
- Journal
- Retina
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1097/iae.0000000000004440
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71